GlassScriptPhysician profile
Nnenna Nwizu
NPI 1578011003
$2,821.96
in general payments reported to CMS, 2019-2025
26 companies · $663 in 2025
The $663 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.97 · 2022: $381 · 2023: $742 · 2024: $1,005 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $447.44 | 2022-2025 | |
| Lilly USA, LLC | $439.12 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $249.35 | 2022-2024 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $239.94 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $199.84 | 2022-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $176.61 | 2022-2025 | Arexvy, Shingrix, Bexsero |
| Kowa Pharmaceuticals America, INC. | $149.67 | 2021-2025 | Livalo, Zoryve |
| Pfizer INC. | $148.20 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.09 | 2022-2025 | |
| Exact Sciences Corporation | $105.08 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.34 | 2022-2025 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $58.25 | 2022 | |
| Sumitomo Pharma America, INC. | $56.34 | 2023-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $54.06 | 2024-2025 | |
| Corium, LLC | $51.36 | 2023-2024 | Azstarys |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $39.14 | 2022-2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $34.99 | 2023 | |
| Edwards Lifesciences Corporation | $34.12 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Organon LLC | $33.18 | 2025 | Nexplanon |
| Astellas Pharma US INC | $27.28 | 2023 | Veozah |
| Insulet Corporation | $27.23 | 2023 | Omnipod |
| Cranial Technologies, INC | $19.81 | 2023 | Doc Band |
| Janssen Pharmaceuticals, INC | $14.89 | 2022 | |
| Sanofi Pasteur INC. | $13.60 | 2022 | |
| Heartflow, INC. | $13.58 | 2022 | |
| Inspire Medical Systems, INC. | $13.45 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nnenna Nwizu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.